Evidence map›Paper›PMID 30669303›Full record

ReviewHigh-throughput2019

A Selective Review of Multi-Level Omics Data Integration Using Variable Selection.

Cen Wu, Fei Zhou, Jie Ren, Xiaoxi Li, Yu Jiang, Shuangge Ma

Abstract readReview
In one paragraph

Review in High-throughput, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Statistical genomics in rare cancer.Seminars in cancer biology · 2020
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Artificial Intelligence-Driven Multi-Omics Approaches in Glioblastoma.International journal of molecular sciences · 2025
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cen WuDepartment of Statistics, Kansas State University, Manhattan, KS 66506, USA. wucen@ksu.edu.
Fei ZhouDepartment of Statistics, Kansas State University, Manhattan, KS 66506, USA. feiz@ksu.edu.
Jie RenDepartment of Statistics, Kansas State University, Manhattan, KS 66506, USA. jieren@ksu.edu.
Xiaoxi LiDepartment of Statistics, Kansas State University, Manhattan, KS 66506, USA. xiaoxili@ksu.edu.
Yu JiangDivision of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, TN 38152, USA. yjiang4@memphis.edu.ORCID 0000-0002-2437-9268
Shuangge MaDepartment of Biostatistics, School of Public Health, Yale University, New Haven, CT 06510, USA. shuangge.ma@yale.edu.

Funding

Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Harriet M. Kluger · 2015 to 2026
$31.1M
Novel methods for identifying genetic interactions in cancer prognosisR01CA204120 · NCI · YALE UNIVERSITY · PI Shuangge Ma · 2016 to 2026
$3.5M
Penalization methods for identifying gene envrionment interactions and applications to melanoma and other cancer typesR21CA191383 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE · 2015 to 2017
$435k
NCI NIH HHS P50 CA196530NCI NIH HHS R01 CA204120NCI NIH HHS R21 CA191383
6 · The paper itself

Abstract

High-throughput technologies have been used to generate a large amount of omics data. In the past, single-level analysis has been extensively conducted where the omics measurements at different levels, including mRNA, microRNA, CNV and DNA methylation, are analyzed separately. As the molecular complexity of disease etiology exists at all different levels, integrative analysis offers an effective way to borrow strength across multi-level omics data and can be more powerful than single level analysis. In this article, we focus on reviewing existing multi-omics integration studies by paying special attention to variable selection methods. We first summarize published reviews on integrating multi-level omics data. Next, after a brief overview on variable selection methods, we review existing supervised, semi-supervised and unsupervised integrative analyses within parallel and hierarchical integration studies, respectively. The strength and limitations of the methods are discussed in detail. No existing integration method can dominate the rest. The computation aspects are also investigated. The review concludes with possible limitations and future directions for multi-level omics data integration.

Indexed as

Bayesian variable selectionintegrative analysismulti-level omics dataparallel and hierarchical integrationPenalization

Identifiers

PMID30669303
PMCPMC6473252

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.